Original ResearchBrief ReportTransfer of Intestinal Microbiota From Lean Donors Increases Insulin Sensitivity in Individuals With Metabolic Syndrome
Brief Report
Section snippets
Acknowledgments
The authors would like to thank Irene Lenoir–Wijnkoop, Remi Brazeilles, and Pascale Rondeau (Danone Research) for valuable comments on the protocol design and statistical analyses. Finally, the authors are grateful to Ineke Heikamp-de Jong, Philippe Puylaert, and Wilma Akkermans-van Vliet (Wageningen University) for excellent laboratory assistance.
References (15)
Nature
(2010)Nature
(2006)Proc Natl Acad Sci U S A
(2004)Diabetes Obes Metab
(2012)Int J Obes (Lond)
(2008)Nature
(2008)J Clin Endocrinol Metab
(2008)
There are more references available in the full text version of this article.
Cited by (2200)
Dissecting mechanisms of fecal microbiota transplantation efficacy in disease
2024, Trends in Molecular MedicineLong-Term Safety Outcomes of Fecal Microbiota Transplantation: Real-World Data Over 8 Years From the Hong Kong FMT Registry
2024, Clinical Gastroenterology and HepatologyHistory of the microbiota, determinant of metabolic diseases
2024, Medecine des Maladies MetaboliquesGut-liver axis: Pathophysiological concepts and medical perspective in chronic liver diseases
2024, Seminars in ImmunologyExploring the oral-gut linkage: Interrelationship between oral and systemic diseases
2024, Mucosal Immunology
Conflicts of interest The authors disclose no conflicts.
Funding Supported by an NWO-VENI grant 2008 (016.096.044 to M.N.), Netherlands Foundation for Cardiovascular Excellence (2008-5 to A.V.), an NWO-ZONMW VEMI grant (170881001 to E.v.N.), and an NWO-Spinoza grant 2008 (W.M.d.V.).
Copyright © 2012 AGA Institute. Published by Elsevier Inc. All rights reserved.